Boehringer Ingelheim Vetmedica GmbH

Company Premium

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

 

Risk and/or triggering factors of porcine circovirus

Between 1995 and 1997, at the beginning of an epizootic called “maladie de l’amagrissement du porcelet” (MAP), it was observed that the farms that were most affected and that had the most losses, generally presented obvious deviations from what we would consider to be a suitable management of the animals and facilities. This is why Dr. François Madec made a list of management practices with the aim of improving the anomalous situation observed.

Etiology: porcine circovirus type 2 (PCV2)... where is "agent X"?

Porcine circovirus type 2 is a viral agent with a relatively simple structural organization of which there are two distinct genotypes (1 and 2), it is not clear if they have similar virulence. Since some years ago there has been a hypothesis developing that there exists an “agent X” that would play a role as a trigger factor of the disease in 100% of cases.

History and controversy of disease

Joaquim Segalés, professor at the Universitat Autònoma de Barcelona and researcher at the Centre de Recerca en Sanitat Animal (CReSA) (research centre for animal health), was one of the first researchers to discover PMWS and PDNS in Spain. He will be in charge of this section where every month articles will be published on the latest themes, especially from a practical point of view. These themes will include etiology, patogenicity, epidemiology, diagnostic, treatment and prevention of porcine circovirus-associated diseases. A possible hypothesis will also be presented on the emergence of porcine circovirus on a worldwide level.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 138295Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
BASF

BASF

Company - Other
DanBred

DanBred

Company - Denmark
pig333

pig333

Company - Spain